Skip to main content
Erschienen in: Archives of Virology 10/2018

05.06.2018 | Original Article

Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016–2017

verfasst von: Tatyana N. Ilyicheva, Alexander G. Durymanov, Svetlana V. Svyatchenko, Vasily Yu. Marchenko, Ivan A. Sobolev, Anastasiya Yu. Bakulina, Natalia I. Goncharova, Natalia P. Kolosova, Ivan M. Susloparov, Olga G. Pyankova, Alexander B. Ryzhikov, Rinat A. Maksyutov

Erschienen in: Archives of Virology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

This work aimed to analyze the herd immunity to influenza among a Russian population living in regions with an increased risk of emergence of viruses with pandemic potential, and to isolate and investigate virus strains from severe influenza cases, including fatal cases, during the 2016–2017 epidemic season. In November 2016 – March 2017 highly pathogenic influenza outbreaks were registered in Russia among wild birds and poultry. No cases of human infection were registered. Analysis of 760 sera from people who had contact with infected or perished birds revealed the presence of antibodies to A(H5N1) virus of clade 2.3.2.1c and A(H5N8) virus of clade 2.3.4.4. The 2016–2017 influenza epidemic season in Russia began in weeks 46–47 of 2016 with predominant circulation of influenza A(H3N2) viruses. Strains isolated from severe influenza cases mainly belonged to 3C.2a.2 and 3C.2a.3 genetic groups. Up to the 8th week of 2017 severe influenza cases were often caused by influenza B viruses which belonged to 1A genetic group with antigenic properties similar to B/Brisbane/60/2008. All influenza A and B virus strains isolated in the 2016–2017 epidemic season were sensitive to oseltamivir and zanamivir.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat WHO (2017) FluNet. http://www.who.int/influenza/gisrs_laboratory/flunet/en//. WHO (2017) FluNet. http://​www.​who.​int/​influenza/​gisrs_​laboratory/​flunet/​en/​/​.​
3.
Zurück zum Zitat Rospotrebnarzor (2017) [On the results of influenza and ARD epidemic season of 2016-2017]. Rospotrebnarzor (2017) [On the results of influenza and ARD epidemic season of 2016-2017].
5.
Zurück zum Zitat Marchenko VY, Susloparov IM, Sapronova NY, Goncharova NI, Kolosova NP, Evseenko VA, Svyatchenko SV, P’yankova OG, Ziatdinov VB, Limanskaya OS, Dzhambinov SD, Shendo GL, Mikheev VN, Maksyutov RA, Ryzhikov AB (2017) Characterization of avian influenza H5N8 virus strains that caused the outbreaks in the Russian Federation in 2016–2017. Probl Part Danger Infections. https://doi.org/10.21055/0370-1069-2017-3-68-74 CrossRef Marchenko VY, Susloparov IM, Sapronova NY, Goncharova NI, Kolosova NP, Evseenko VA, Svyatchenko SV, P’yankova OG, Ziatdinov VB, Limanskaya OS, Dzhambinov SD, Shendo GL, Mikheev VN, Maksyutov RA, Ryzhikov AB (2017) Characterization of avian influenza H5N8 virus strains that caused the outbreaks in the Russian Federation in 2016–2017. Probl Part Danger Infections. https://​doi.​org/​10.​21055/​0370-1069-2017-3-68-74 CrossRef
6.
Zurück zum Zitat WHO (2011) World Health Organization Surveillance Network: manual for the laboratory diagnosis and virological surveillance of influenza. World Health Organization, Geneva WHO (2011) World Health Organization Surveillance Network: manual for the laboratory diagnosis and virological surveillance of influenza. World Health Organization, Geneva
7.
Zurück zum Zitat Marchenko VY, Susloparov IM, Komissarov AB, Fadeev A, Goncharova NI, Shipovalov AV, Svyatchenko SV, Durymanov AG, Ilyicheva TN, Salchak LK, Svintitskaya EP, Mikheev VN, Ryzhikov AB (2017) Reintroduction of highly pathogenic avian influenza A/H5N8 virus of clade 2.3.4.4. in Russia. Arch Virol 162(5):1381–1385. https://doi.org/10.1007/s00705-017-3246-z CrossRefPubMed Marchenko VY, Susloparov IM, Komissarov AB, Fadeev A, Goncharova NI, Shipovalov AV, Svyatchenko SV, Durymanov AG, Ilyicheva TN, Salchak LK, Svintitskaya EP, Mikheev VN, Ryzhikov AB (2017) Reintroduction of highly pathogenic avian influenza A/H5N8 virus of clade 2.3.4.4. in Russia. Arch Virol 162(5):1381–1385. https://​doi.​org/​10.​1007/​s00705-017-3246-z CrossRefPubMed
9.
Zurück zum Zitat Katz J, Hancock K, Veguilla V, Zhong W, XH L, Sun H, Butler E, Dong L, Liu F, Li ZN, DeVos J, Gargiullo P, Cox N (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morb Mortal Wkly Rep 58(19):521–524 Katz J, Hancock K, Veguilla V, Zhong W, XH L, Sun H, Butler E, Dong L, Liu F, Li ZN, DeVos J, Gargiullo P, Cox N (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morb Mortal Wkly Rep 58(19):521–524
10.
Zurück zum Zitat WHO (2007) Standard operating procedure WHO—025: fluorometric neuraminidase inhibition assay. WHO, Geneva WHO (2007) Standard operating procedure WHO—025: fluorometric neuraminidase inhibition assay. WHO, Geneva
14.
Zurück zum Zitat Kratsch C, Klingen TR, Mumken L, Steinbruck L, McHardy AC (2016) Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 viruses. Virus Evol 2(1):vv025 (10.1093/ve/vev025) CrossRef Kratsch C, Klingen TR, Mumken L, Steinbruck L, McHardy AC (2016) Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 viruses. Virus Evol 2(1):vv025 (10.1093/ve/vev025) CrossRef
20.
Zurück zum Zitat Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowal MP, Jackson MJ, Jackson LA, Foust A, Sessions W, Berman L, Spencer S (2017) Fry AM (2017) Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness—United States. Morb Mortal Wkly Rep 66(6):167–171. https://doi.org/10.15585/mmwr.mm6606a3 CrossRef Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowal MP, Jackson MJ, Jackson LA, Foust A, Sessions W, Berman L, Spencer S (2017) Fry AM (2017) Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness—United States. Morb Mortal Wkly Rep 66(6):167–171. https://​doi.​org/​10.​15585/​mmwr.​mm6606a3 CrossRef
21.
Zurück zum Zitat CDC (2018) Weekly U.S. Influenza Surveillance Report. https://www.cdc.gov/flu/weekly/ CDC (2018) Weekly U.S. Influenza Surveillance Report. https://​www.​cdc.​gov/​flu/​weekly/​
22.
Zurück zum Zitat Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Northern Hemisphere 2017–2018 (2017). The Crick Worldwide Influenza Centre, London Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Northern Hemisphere 2017–2018 (2017). The Crick Worldwide Influenza Centre, London
Metadaten
Titel
Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016–2017
verfasst von
Tatyana N. Ilyicheva
Alexander G. Durymanov
Svetlana V. Svyatchenko
Vasily Yu. Marchenko
Ivan A. Sobolev
Anastasiya Yu. Bakulina
Natalia I. Goncharova
Natalia P. Kolosova
Ivan M. Susloparov
Olga G. Pyankova
Alexander B. Ryzhikov
Rinat A. Maksyutov
Publikationsdatum
05.06.2018
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 10/2018
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-3904-9

Weitere Artikel der Ausgabe 10/2018

Archives of Virology 10/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.